CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
metformin XR +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00068861
NCT00068861Phase 3Completed
CompareCT.gov

Pregnancy in Polycystic Ovary Syndrome: A 30 Week Double-Blind Randomized Trial of Clomiphene Citrate, Metformin XR, and Combined Clomiphene Citrate/Metformin XR For the Treatment of Infertility in Women With Polycystic Ovary Syndrome

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·interventional·Posted Sep 11, 2003·Updated Oct 1, 2007

In Brief

A Phase 3 clinical trial evaluating metformin XR and clomiphene citrate for Polycystic Ovary Syndrome and 2 related conditions. Completed, across 11 sites.

Detailed Summary

Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of women. The primary symptoms of PCOS are menstrual irregularities, increased body and facial hair, acne, and infertility. This study will test a combination of medications in women with PCOS to determine which works best to overcome infertility.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovary Syndrome, Infertility, Pregnancy
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 11, 2003
Enrollment StartNov 1, 2002
Study CompletionFeb 1, 2006
TodayJul 2, 2026
Posted 22.8 years ago

Interventions

metformin XRdrug

clomiphene citratedrug